MRC1 and neoplasm: Anti‐Chi3L1 antibody‐treated tumor tissues promoted ARG1 and CD206 expression inhibition compared with vehicle‐treated tumor tissues but did not change iNOS and CD86 expression (Fig. 4C,D).